ALM-401

About Almac

Almac Group is a large, privately-held, revenue-generating CDMO and service provider with a significant global footprint. The company has demonstrated strong growth, surpassing £1 billion in revenue, and supports approximately 50% of approved new molecular entities (NMEs). Its business model is centered on providing comprehensive, outsourced services including drug discovery, diagnostic development, clinical trial supply management, and pharmaceutical manufacturing. Recent multi-million-pound investments in new facilities and technologies underscore its expansion strategy and commitment to sustainability.